Abstract | OBJECTIVE: DESIGN: Fifty-nine type 2 diabetic patients and thirty-one non-diabetic controls were included in this study. RESULTS: Mean serum IGF-I levels in diabetic patients were lower than the non-diabetic controls (158+/-12 vs. 287+/-26microg/l), (p<0.001). Serum IGFBP-1 levels were also higher in type 2 diabetic patients compared to the control group (67+/-5 vs. 35+/-4microg/l), (p<0.001). No relationship was obtained between IGF-I and IGFBP-1 levels with neither UAE nor urinary NAG excretion. A significant negative relationship was observed between creatinine clearance and serum IGFBP-1 level (r=-0.39, p=0.004). In multiple regression analysis IGF-I was independently and negatively associated with age and insulin treatment. On the other hand, IGFBP-1 was negatively related with creatinine clearance and positively related with the duration of diabetes. CONCLUSION: These results suggest that type 2 DM leads to a decrease in the IGF-I while elevating the IGFBP-1 levels. Further studies are needed to clarify a potential role of increased levels of IGFBP-1 in decreased creatinine clearance in type 2 DM.
|
Authors | Mujde Akturk, Metin Arslan, Alev Altinova, Aysegul Ozdemir, Reyhan Ersoy, Ilhan Yetkin, Elif Ayvali, Sevim Gonen, Fusun Toruner |
Journal | Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
(Growth Horm IGF Res)
Vol. 17
Issue 3
Pg. 186-93
(Jun 2007)
ISSN: 1096-6374 [Print] Scotland |
PMID | 17329141
(Publication Type: Journal Article)
|
Chemical References |
- Insulin-Like Growth Factor Binding Protein 1
- Insulin-Like Growth Factor I
- Creatinine
- Acetylglucosaminidase
|
Topics |
- Acetylglucosaminidase
(urine)
- Creatinine
(urine)
- Diabetes Mellitus, Type 2
(blood)
- Female
- Humans
- Insulin-Like Growth Factor Binding Protein 1
(blood)
- Insulin-Like Growth Factor I
(analysis)
- Kidney
(physiopathology)
- Male
- Middle Aged
|